Volltextsuche
Hinweis: Bitte geben Sie einen Suchbegriff ein, z.B. "BMW", um alle Analysen und News über BMW aufgelistet zu bekommen, die innerhalb der Site von AktienCheck vorhanden sind! Zusätzlich können Sie noch eine Zeitspanne auswählen.
Suchergebnisse: (34004 Ergebnisse gefunden) Es w.
| Datum | Thema | |
|---|---|---|
| 07.04.26 | Spyre Therapeutics Aktie: Expansion geplant | |
| Spyre Therapeutics setzt auf personelles Wachstum, um seine Ziele im Bereich spezialisierter medizinischer Lösungen zu erreichen. Das Unternehmen nutzt gezielte Aktienoptionen, um neue Fachkräfte langfristig zu binden und deren Interessen mit der Wertentwicklung am Kapitalmarkt zu verknüpfen. [...] | ||
| 07.04.26 | Nestlé Faces Shareholder Scrutiny Amid Strategic Crossroads | |
| Nestlé finds itself navigating a dual challenge as its annual general meeting approaches. The consumer goods giant is contending with a decline in sales volume that calls its longstanding pricing model into question, while simultaneously undertaking a significant overhaul of its board's composition and committee structure. [...] | ||
| 07.04.26 | Air Liquide Investors Await First Quarter Results | |
| A period of mandated silence between the industrial gases giant Air Liquide and the capital markets begins tomorrow. This quiet period precedes the release of the first concrete financial data for the new fiscal year, setting the stage for a crucial evaluation of the company's early 2026 trajectory. [...] | ||
| 07.04.26 | Nvidia's Stock: A Valuation Disconnect Emerges Amid Unprecedented AI Demand | |
| A striking divergence is unfolding for Nvidia Corporation. While demand for its artificial intelligence chips is accelerating at a breathtaking pace, the company's shares are trading at their most modest valuation in ten years. This presents a seemingly contradictory picture for the dominant force in AI hardware. [...] | ||
| 07.04.26 | BioNTech Sharpens Its Strategic Edge with Oncology Push | |
| In a decisive strategic pivot, BioNTech is streamlining its operations to concentrate its resources fully on cancer therapeutics. This shift is marked by significant operational changes, including the closure of a key manufacturing facility and the discontinuation of a major vaccine trial, underscoring a deliberate move away from its pandemic-era focus. [...] | ||
| 07.04.26 | Broadcom's AI Ambition: A $100 Billion Revenue Target Fuels Investor Confidence | |
| Driven by a bold strategic vision from CEO Hock Tan, Broadcom has set a definitive goal: generating over $100 billion in revenue from its artificial intelligence segment by fiscal year 2027. This ambitious target is generating substantial optimism on Wall Street, prompting a wave of bullish analyst recommendations and highlighting significant upside potential for the semiconductor giant. [...] | ||
| 07.04.26 | The Trade Desk Navigates Growth Transition Amid Strategic Overhaul | |
| Analysts have tempered their near-term outlook for The Trade Desk following a corporate forecast that signals a deceleration from its historically rapid expansion. The digital advertising technology firm is undertaking a significant platform transformation, introducing new AI-powered trading models designed to enhance customer efficiency. [...] | ||
| 06.04.26 | Altai Announces Transfer of Listing to NEX | |
| TORONTO, April 06, 2026 (GLOBE NEWSWIRE) -- Altai Resources Inc. (NEX: ATI.H) (“Altai” or the “Company”) announced that, effective today, the TSX Venture Exchange (the “TSXV”) has transferred the listing of the common shares of the Company (the “Common Shares”) to the NEX board of the TSXV (the “NEX”) and has withdrawn the 90-day Notice to Transfer to NEX that had been previously issued by the TSXV and that had been announced by the Company in its news release dated February 17, 2026, as instructed by the TSXV. [...] | ||
| 06.04.26 | Avicanna Announces Changes to its Board of Directors | |
| TORONTO, April 06, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products announces effective Thursday April 1, 2026 the resignation of John McVicar and pleased to announce the appointment of Mr. [...] | ||
| 06.04.26 | Mawson Infrastructure Group Inc. Provides Governance Update | |
| Enters Cooperation Agreement with Endeavor Investor Group to Reconstitute Board Enters Cooperation Agreement with Endeavor Investor Group to Reconstitute Board. [...] |
